butylstannane. To prepare the target dichloride, decarboxy-
lation of acid 16 was required in the presence of a hydride
source which would not lead to concomitant reduction of
the dichloride. The key to the success of this reaction was
treatment of 16 with Pb(OAc)4 in the presence of 1,4-
cyclohexadiene generating the required dichloromethyl prod-
uct 17 in 58% yield.
A more succinct approach to the required gem-dichloride
is directly from aldehyde 11. Several methods are known
for the conversion of aldehydes to dichlorides; however, we
have found, for example, that use of Ph3P/CCl4/Et3N led to
a vinyl dichloride,9 whereas under more forcing conditions,
e.g., SOCl2/DMF or PCl5, decomposition occurred. Recently,
Rodr´ıguez19 reported a valuable modification of the Takeda
conditions (involving treatment of an aldehyde with hydra-
zine monohydrate in anhydrous MeOH followed by reaction
with copper(II) chloride20) in the synthesis of dichloroleucine
which has been used by the group of Walsh6a as well as by
Gerwick Sherman, Willis, and co-workers in biosynthetic
studies on barbamide.6b Using this method, we converted
aldehyde 11 directly to the required dichloride 17; however,
we found that the reaction was capricious and yields varied
from 30 to 45% (Scheme 4). Other solvents were examined
our goal was to investigate a general approach which could
be adapted for the synthesis of a series of symmetrical and
unsymmetrical dysamides. Interestingly, in 1978 Wells and
co-workers reported the isolation of a series of secondary
metabolites from Dysidea herbacea including chlorinated
diketopiperazines which, on reduction, gave a symmetrical
diketopiperazine assembled from N-methylleucine.23 The
absolute and relative stereochemistry of the product was not
assigned.
Matsunari and co-workers have reported the only synthesis
of such a symmetrical diketopiperazine, and their approach
began with a thermal dehydration of L-leucine to give
diketopiperazine 18 (Scheme 5). N-Methylation of 18 with
Scheme 5. Synthesis of Diketopiperazines 19 and 2024
Scheme 4. Synthesis of Protected 5,5-Dichloroleucine 17
MeI and silver oxide gave the cis product 19 in 10% yield,
and with NaH and MeI, approximately a 1:2 mixture of cis-
and trans-diketopiperazines 19 and 20 was obtained which
were separated by fractional crystallization.24 Thus, 19 was
selected as our initial target to develop the synthesis of
diketopiperazines by an approach which could be adapted
for the preparation of symmetrical and unsymmetrical
products
The strategy involved coupling of two orthogonally
protected N-methyl amino acids 23 and 24 followed by
deprotection and cyclization (Scheme 6). First, N-methylation
was achieved by treatment of Cbz-L-leucine 21 with sodium
hydride and methyl iodide in either CH3CN or THF/DMF
to give the known acid 24 and methyl ester 22, respectively.25
Removal of the Cbz group in 22 with HBr/AcOH gave the
required secondary amine 23 in 88% yield. With both the
orthogonally protected amino acids 23 and 24 in hand, next
it was necessary to couple them using conditions which
would not lead to racemization. Several standard coupling
conditions were investigated (including HOAt, EDCI, NaH-
CO3 and HOBt, and DCC)26 which indeed gave the required
dipeptide 25, but the optimum yield was achieved using
BOPCl/Et3N to give 25 as a single diastereomer.27 To
complete the synthesis of the model diketopiperazine 19, the
Cbz group was removed from 25 using HBr/AcOH followed
including dichloromethane, toluene, and isobutanol, but these
gave a lower yield of the required gem-dichloride.
The final stage of the synthesis of dichloroleucine 1 was
removal of the Boc group and hydrolysis of the tert-butyl
ester. Interestingly, treatment of 17 with concentrated HCl
under reflux led to the formation of a quantity (ca. 15%) of
a byproduct tentatively identified as vinyl chloride (1H NMR
δ1.82, d, J ) 1.5 Hz, 4-CH3 and δ6.15, br. s, dCHCl; 13C
NMR δ141.2, C-4 and δ110.0, C-5), an observation also
noted by Macko et al.21 in the hydrolysis of the fungal
phytotoxin victorin C. It was possible to avoid formation of
this unwanted byproduct by carrying out the deprotection in
neat TFA giving 1 in quantitative yield after ion-exchange
chromatography. With quantities of (2S,4S)-dichloroleucine
1 in hand, next we turned to the synthesis of dysamide B
(3).
Several methods have been reported for the synthesis of
diketopiperazines,22 and although dysamide B is symmetrical,
(19) Arda´, A.; Jime´nez, C.; Rodr´ıguez, J. Tetrahedron Lett. 2004, 45,
3241.
(20) Takeda, T.; Sasaki, R.; Yamaguchi, S.; Fujiwara, T. Tetrahedron
1997, 53, 557.
(21) Macko, V.; Wolpert, T. J.; Acklin, W.; Juan, B.; Seibl, J.; Meili, J.;
Arigoni, D. Experientia 1985, 41, 1366.
(23) Kazlauskas, P.; Murphy, P. T.; Wells, R. J. Tetrahedron Lett. 1978,
49, 4945.
(24) Yoshimura, J.; Nakamura, H.; Matsanuri, K. Bull. Chem. Soc. Jpn.
1975, 48, 605.
(22) (a) Hulme, C.; Morrissette, M.; Volz, F.; Burns, C. Tetrahedron
Lett. 1998, 39, 1113. (b) Siwicka, A.; Wojtasiewicz, K.; Rosiek, B.;
Leniewski, A.; Maurin, J. K.; Czarnocki, Z. Tetrahedron: Asymmetry 2005,
16, 975. (c) Dinsmore, C. J.; Beshore, D. C. Tetrahedron 2002, 58, 3297.
(25) Cheung, S.; Benoiton, T. Can. J. Chem. 1977, 55, 916.
(26) Chen, Y.; Bilban, M.; Foster, C. A.; Foster, D. L. J. Am. Chem.
Soc. 2002, 124, 5431.
(27) Tung, R. D.; Rich, D. H. J. Am. Chem. Soc. 1985, 107, 4342.
Org. Lett., Vol. 8, No. 23, 2006
5403